SP

Sunil Pandey Kumar

Active Director Director DIN 00926071
DIN 00926071 First appointment Nov 2006 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2006
Shareholding value •••• Premium profile

About Sunil Pandey Kumar

Data last updated:

Sunil Pandey Kumar is a Director at Human Antibiotic Pharmceutical Private Limited (since 2006). The company operates in Chemicals. Human Antibiotic Pharmceutical Private Limited reported revenue of ₹4.67 Cr (FY 2024).

DIN 00926071
Primary Designation Director
Industry Chemicals
First Appointment 28 Nov 2006
Oldest Company Age 19 yrs
Largest company Human Antibiotic Pharmceutical Private Limited · ₹4.67 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Nov 20062006₹4.67 Cr (FY 2024)Active

Board colleagues of Sunil Pandey Kumar

Directorship timeline

Open interactive timeline →
Human Antibiotic Pharmceutical Private Limited
Premium access

Shareholding and investment profile for Sunil Pandey Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Pandey Kumar

Sunil Pandey Kumar currently holds 1 directorship: Human Antibiotic Pharmceutical Private Limited (Director, since 28 Nov 2006, revenue ₹4.67 Cr (FY 2024)).

Sunil Pandey Kumar was first appointed on 28 Nov 2006 as Director at Human Antibiotic Pharmceutical Private Limited.

The current boards of Sunil Pandey Kumar's companies include Avinash Gupta Kumar (Human Antibiotic Pharmceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available